How can Jivi help my patients?

Every patient is different and
their needs change over time

Omar, 14

Omar is at school and wants to keep up with his friends, but his parents worry about bleeds and a possible impact on his joints.

Raul, 14

Raul has moderate hemophilia and uses on-demand SHL treatment. He wants to be more active and keep his number of infusions low.

Max, 18

Max is about to start college and needs more time to be active.

Bob, 25

Bob is starting out in his career and wants fewer infusions so he can focus more on his life goals.

Gary, 35

Gary has a young family and is beginning to struggle with joint pain.

Jason, 45

Jason is using on-demand treatment and wants less pain.

Carlos, 50

Carlos has cardiovascular comorbidities and needs a treatment that offers powerful protection without exacerbating his hypertension.

References

Jivi Summary of Product Characteristics. Return to content
Reding MT et al. Haemophilia 2021; 00: 1–10. Return to content
Reding MT et al. Haemophilia 2020;26:e201–e204. Return to content
Shah A et al. Ann Hematol 2019; 98(9): 2035-2044. Return to content
Reading MT et al. J Thromb Haemost 2017; 15: 411-419. Return to content
Lalezari S et al. Haemophilia. 2019; 25: 1011-1019 Return to content
Solms A, et al. Ann Hematol 2020; 99, 2689–2698 Return to content
Berntorp E et al. Blood Rev; 2021: https://doi.org/10.1016/j.blre.2021.100852 (epub ahead of print). Return to content

This website is for healthcare professionals only If you are a healthcare professional, please select your country to visit your local website:

Discover the power of Jivi

Every patient is different andtheir needs change over time

Omar, 14

Raul, 14

Max, 18

Bob, 25

Gary, 35

Jason, 45

Carlos, 50

References

Omar, 14

For young patients like Omar, Jivi delivers:1,2

Joint protection that lasts†

Powerful protection from bleeds

See your young patients through the adventures of adolescence with Jivi

Raul, 14

Jivi’s powerful protection from bleeds and 1x weekly dosing option helps ease your mild-to-moderate patients like Raul into prophylaxis.1,2

Ease your mild-to-moderate patients into prophylaxis with Jivi’s powerful protection

Max, 18

For patients like Max, Jivi delivers1-4

Jivi gives patients more time to do what matters to them

Bob, 25

For patients like Bob, who want to achieve more with fewer infusions, Jivi delivers powerful protection1 with higher and more sustained FVIII levels2,3†

With Jivi, your patients like Bob can focus on life, not treatment

Gary, 35

For patients like Gary, who are experiencing joint pain, Jivi delivers powerful protection from joint damage:

Strengthen your patients’ futures with Jivi

Jason, 45

Jivi’s powerful protection from bleeds and 1x weekly dosing option helps ease your on-demand patients, like Jason, into prophylaxis.1,2 †

For patients like Jason, Jivi prophylaxis is a small step that delivers powerful protection

Carlos, 50

For patients with age-related comorbidities like Carlos, Jivi provides powerful protection with the reassurance of no observed cardiovascular events:1

Give your patients powerful protection with the reassurance of no associated thrombotic risk

This website is for healthcare professionals only

If you are a healthcare professional, please select your country to visit your local website:

Every patient is different and
their needs change over time

For young patients like Omar, Jivi delivers:^1,2

Joint protection that lasts^†

Jivi’s powerful protection from bleeds and 1x weekly dosing option helps ease your mild-to-moderate patients like Raul into prophylaxis.^1,2

For patients like Max, Jivi delivers^1-4

For patients like Bob, who want to achieve more with fewer infusions, Jivi delivers powerful protection¹ with higher and more sustained FVIII levels^2,3†

Jivi’s powerful protection from bleeds and 1x weekly dosing option helps ease your on-demand patients, like Jason, into prophylaxis.^{1,2 †}

For patients with age-related comorbidities like Carlos, Jivi provides powerful protection with the reassurance of no observed cardiovascular events:¹